US Broker Ratings

Aveanna Healthcare Holdings Inc (AVAH) Stock Report: Evaluating the 10.34% Potential Upside for Investors

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) stands as a unique player in the U.S. healthcare sector, specifically within the Medical Care Facilities industry. As a diversified home care platform, Aveanna..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Strategizing for a 117% Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents an intriguing opportunity for investors, especially given the substantial potential upside of 117.48% indicated by analyst targets. As a player in the biotechnology sector,..

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 89% Upside Potential in the Healthcare Sector

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is currently trading at $25.28, with investors keenly watching its potential for growth. With a market cap of..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 74.25% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices, has been drawing attention with its innovative solutions tailored for diabetes management. Headquartered..

Teladoc Health, Inc. (TDOC) Investor Outlook: A 21% Potential Upside Amidst Mixed Ratings

Teladoc Health, Inc. (TDOC), a pioneering entity in the health information services sector, provides a wide array of virtual healthcare services globally. As the healthcare industry increasingly embraces digital transformation,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Powerhouse with Nearly 200% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine. Based in Singapore, this clinical-stage company is dedicated to designing,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring the 50% Upside Potential in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector with its innovative approach to providing outpatient mental health services across the United States. Headquartered in Scottsdale,..

Indivior PLC (INDV) Stock Analysis: Exploring a 9.21% Potential Upside Amidst Strategic Developments

Indivior PLC (INDV) stands at a pivotal juncture in its journey within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic applications. With a market..

Viridian Therapeutics, Inc. (VRDN): Analyst Ratings Reveal 157% Upside Potential in Biotech Innovator

Viridian Therapeutics, Inc. (VRDN), a biotech company focused on developing novel treatments for rare and serious diseases, has captured the attention of investors with its promising product pipeline and substantial..

Harrow, Inc. (HROW) Investor Outlook: Analyst Ratings Shine Amid 81% Potential Upside

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector specializing in ophthalmic pharmaceuticals, is capturing investor attention with significant potential gains on the horizon. With an impressive market..

agilon health, inc. (AGL) Investor Outlook: Assessing Growth Potential Amid an 86% Upside

Agilon health, inc. (NYSE: AGL), a prominent player in the healthcare sector, specializes in providing comprehensive care solutions for seniors through primary care networks across the United States. Despite its..

Veracyte, Inc. (VCYT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 47%

Veracyte, Inc. (VCYT), a healthcare company specializing in diagnostics and research, has caught the attention of investors with its promising growth potential. Headquartered in South San Francisco, California, Veracyte operates..

MiMedx Group, Inc (MDXG) Investor Outlook: Potential 86% Upside Makes This Biotech Stock an Intriguing Bet

MiMedx Group, Inc (NASDAQ: MDXG) is a biotechnology company specializing in healthcare solutions, with a focus on developing placental tissue allografts for medical applications. Headquartered in Marietta, Georgia, MiMedx has..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A 162% Potential Upside Captures Investor Attention

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a notable player in the biotechnology sector, has been capturing the attention of investors with its focus on rare disease treatments. Headquartered in Princeton, New..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 142% Potential Upside with Strong Buy Ratings

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector with its promising clinical-stage developments, particularly its flagship product candidate, lorundrostat. With a market capitalization of $1.06 billion,..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 24.77% Potential Upside for Investors

Schrodinger, Inc. (NASDAQ: SDGR) is capturing the attention of investors with its promising potential upside of 24.77%, as indicated by the latest analyst ratings. Operating at the intersection of healthcare..

Sotera Health Company (SHC) Stock Analysis: Unlocking a 20% Upside Potential

Sotera Health Company (NASDAQ: SHC) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Broadview Heights, Ohio, Sotera..

Galapagos NV (GLPG) Stock Analysis: Navigating Biotech’s Challenges with a 1.11% Potential Upside

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is making headlines with its innovative focus on oncology and immunology. With a market capitalization of $1.88 billion, the company is a..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 42% Upside Potential in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a noteworthy player in the healthcare sector, specializes in providing cutting-edge biological and chemical compound sample exploration and management solutions. With a current market capitalization of..

NeoGenomics, Inc. (NEO) Investor Outlook: A 48.81% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, specializes in diagnostics and research with a particular focus on cancer testing. Headquartered in Fort Myers, Florida, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds